| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871554 | The Annals of Thoracic Surgery | 2016 | 7 Pages |
Abstract
TAVR and AVB relieve aortic stenosis and have similar and acceptable procedural mortality rates. AVB-treated patients had 1.75 times the STS risk score when compared with the TAVR cohort. Hospital charges for TAVR were nearly twofold those of AVB. Hospital reimbursement was similar, but AVB had two to four times the profit margin of TAVR. Longer follow-up for the TAVR cohort will determine whether survival is comparable to that after AVB at 3 and 5 years.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
John W. MD, Jack H. MD, Parth M. MS, Mary L. BSN, Amjad MD, Joe MS, Joel MD,